Loading…
GAVISCON ADVANCE MINT is a brand name for Potassium Bicarbonate. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Treatment of symptoms resulting from the reflux of acid, bile and pepsin into the oesophagus such as acid regurgitation, heartburn, indigestion (occurring due to the reflux of stomach contents), for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy, accompanying reflux oesophagitis,…
Verbatim from this product's MHRA label. Tap a section to expand.
For oral administration, after being thoroughly chewed.
Adults and children 12 years and over:
One to two tablets after meals and at bedtime.
Children under 12 years:
Should be given only on medical advice.
Elderly:
No dose modifications necessary for this age group.
Hepatic Impairment:
No dose modification necessary. 4).
Adverse reactions have been ranked under headings of frequency using the following convention: very common (1/10), common (1/100 and <1/10), uncommon (1/1000 and <1/100), rare (1/10,000 and <1/1000), very rare (< 1/10,000) and not known (cannot be estimated from the available data).
System Organ Class Frequency Adverse Event Gastrointestinal Disorders Uncommon Diarrhoea, nausea, vomiting. Immune System Disorders Very rare Anaphylactic and anaphylactoid reactions. Hypersensitivity reactions such as urticaria. Respiratory, Thoracic and Mediastinal Very rare Respiratory effects such as bronchospasm.
Disorders Reporting of Suspected Adverse Reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
If symptoms do not improve after 7 days, the clinical situation should be reviewed. 7% of the WHO recommended maximum daily intake for sodium. 28 % of the WHO recommended maximum daily intake for sodium. This product is considered high in sodium.
g. in some cases of congestive heart failure and renal impairment). 43 mg) per tablet. To be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet. 0 mmol) of calcium carbonate. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi.
5 mg aspartame (E 951) in each tablet. Aspartame (E 951) is a source of phenylalanine. It may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.
May cause central nervous system depression in the presence of renal insufficiency and should not be used in patients with renal failure.
1.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Potassium Bicarbonate in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.